ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

Data as of Jan 26
 -0.0011 / -0.16%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

ImmunoCellular Therapeutics Ltd. is a clinical-stage biotechnology company, which focuses on developing immune-based therapies for the treatment of brain and other cancers. Its cell-based vaccine technologies are primary platform technologies and commercial prospects will be heavily dependent on the outcome of the contemplated clinical trials for current lead vaccine product candidate. Its product pipeline includes peptide based vaccine to target cancer stem cells, cellular immunotherapies to target cancer associated antigens, and monoclonal antibodies to diagnose and treat several different cancers. ImmunoCellular product candidates include ICT-107, CT-121, ICT-109, ICT-037, ICT-69 and CT-Diagnostic-SCLC. Its antibodies are designed to treat small cell lung cancer, pancreatic cancer, multiple myeloma and ovarian cancer. The company was founded on March 20, 1987 and is headquartered in Woodland Hills, CA.

Contact Information

ImmunoCellular Therapeutics Ltd.
23662 Calabasas Road
Calabasas California 91302
P:(818) 264-2300
Investor Relations:



Mutual fund holders4.25%
Other institutional2.44%
Individual stakeholders1.71%

Top Executives

John S. YuChairman, Secretary & Chief Scientific Officer
Andrew GengosPresident, Chief Executive Officer & Director
Anthony J. GringeriSenior Vice President-Strategic Resources
David E. FractorTreasurer, Chief Accounting Officer & VP-Finance

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.